Intravitreal moxifloxacin in the management of Ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body

David J Jacobs,1,2 Thomas J Grube,3 Harry W Flynn Jr,4 Craig M Greven,5 Avinash Pathengay,6 Darlene Miller,4 Robert F Sanke,1,2 Joseph Thorman7 1Trinity Regional Eyecare, Minot, ND, USA; 2School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND, USA; 3Grube Retina Clinic,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jacobs DJ, Grube TJ, Flynn Jr HW, Greven CM, Pathengay A, Miller D, Sanke RF, Thorman J
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://doaj.org/article/c19a69ac51804ad289230ca2507eb567
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c19a69ac51804ad289230ca2507eb567
record_format dspace
spelling oai:doaj.org-article:c19a69ac51804ad289230ca2507eb5672021-12-02T05:11:47ZIntravitreal moxifloxacin in the management of Ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body1177-54671177-5483https://doaj.org/article/c19a69ac51804ad289230ca2507eb5672013-08-01T00:00:00Zhttp://www.dovepress.com/intravitreal-moxifloxacin-in-the-management-of-ochrobactrum-intermediu-a14173https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483David J Jacobs,1,2 Thomas J Grube,3 Harry W Flynn Jr,4 Craig M Greven,5 Avinash Pathengay,6 Darlene Miller,4 Robert F Sanke,1,2 Joseph Thorman7 1Trinity Regional Eyecare, Minot, ND, USA; 2School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND, USA; 3Grube Retina Clinic, Mandan, ND, USA; 4Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA; 5Department of Ophthalmology, Wake Forest University Eye Center, Winston-Salem, NC, USA; 6LV Prasad Eye Institute, Hyderabad, India; 7Rolla Eye Clinic, ND, USA Abstract: A healthy 34-year-old man presented with Ochrobactrum intermedium endophthalmitis due to a metallic intraocular foreign body. After vitrectomy, lensectomy, removal of the metallic intraocular foreign body, intravitreal vancomycin and ceftazidime, and systemic ciprofloxacin, intraocular inflammation worsened. Repeat vitreous culture confirmed persistent endophthalmitis due to multidrug-resistant O. intermedium. The endophthalmitis successfully resolved after the administration of intravitreal moxifloxacin. Keywords: moxifloxacin, Ochrobactrum intermedium, endophthalmitis, intraocular foreign bodyJacobs DJGrube TJFlynn Jr HWGreven CMPathengay AMiller DSanke RFThorman JDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2013, Iss default, Pp 1727-1730 (2013)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Jacobs DJ
Grube TJ
Flynn Jr HW
Greven CM
Pathengay A
Miller D
Sanke RF
Thorman J
Intravitreal moxifloxacin in the management of Ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body
description David J Jacobs,1,2 Thomas J Grube,3 Harry W Flynn Jr,4 Craig M Greven,5 Avinash Pathengay,6 Darlene Miller,4 Robert F Sanke,1,2 Joseph Thorman7 1Trinity Regional Eyecare, Minot, ND, USA; 2School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND, USA; 3Grube Retina Clinic, Mandan, ND, USA; 4Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA; 5Department of Ophthalmology, Wake Forest University Eye Center, Winston-Salem, NC, USA; 6LV Prasad Eye Institute, Hyderabad, India; 7Rolla Eye Clinic, ND, USA Abstract: A healthy 34-year-old man presented with Ochrobactrum intermedium endophthalmitis due to a metallic intraocular foreign body. After vitrectomy, lensectomy, removal of the metallic intraocular foreign body, intravitreal vancomycin and ceftazidime, and systemic ciprofloxacin, intraocular inflammation worsened. Repeat vitreous culture confirmed persistent endophthalmitis due to multidrug-resistant O. intermedium. The endophthalmitis successfully resolved after the administration of intravitreal moxifloxacin. Keywords: moxifloxacin, Ochrobactrum intermedium, endophthalmitis, intraocular foreign body
format article
author Jacobs DJ
Grube TJ
Flynn Jr HW
Greven CM
Pathengay A
Miller D
Sanke RF
Thorman J
author_facet Jacobs DJ
Grube TJ
Flynn Jr HW
Greven CM
Pathengay A
Miller D
Sanke RF
Thorman J
author_sort Jacobs DJ
title Intravitreal moxifloxacin in the management of Ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body
title_short Intravitreal moxifloxacin in the management of Ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body
title_full Intravitreal moxifloxacin in the management of Ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body
title_fullStr Intravitreal moxifloxacin in the management of Ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body
title_full_unstemmed Intravitreal moxifloxacin in the management of Ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body
title_sort intravitreal moxifloxacin in the management of ochrobactrum intermedium endophthalmitis due to metallic intraocular foreign body
publisher Dove Medical Press
publishDate 2013
url https://doaj.org/article/c19a69ac51804ad289230ca2507eb567
work_keys_str_mv AT jacobsdj intravitrealmoxifloxacininthemanagementofochrobactrumintermediumendophthalmitisduetometallicintraocularforeignbody
AT grubetj intravitrealmoxifloxacininthemanagementofochrobactrumintermediumendophthalmitisduetometallicintraocularforeignbody
AT flynnjrhw intravitrealmoxifloxacininthemanagementofochrobactrumintermediumendophthalmitisduetometallicintraocularforeignbody
AT grevencm intravitrealmoxifloxacininthemanagementofochrobactrumintermediumendophthalmitisduetometallicintraocularforeignbody
AT pathengaya intravitrealmoxifloxacininthemanagementofochrobactrumintermediumendophthalmitisduetometallicintraocularforeignbody
AT millerd intravitrealmoxifloxacininthemanagementofochrobactrumintermediumendophthalmitisduetometallicintraocularforeignbody
AT sankerf intravitrealmoxifloxacininthemanagementofochrobactrumintermediumendophthalmitisduetometallicintraocularforeignbody
AT thormanj intravitrealmoxifloxacininthemanagementofochrobactrumintermediumendophthalmitisduetometallicintraocularforeignbody
_version_ 1718400557862879232